Emergent BioSolutions Inc (EBS)
8.10
+0.04
(+0.50%)
USD |
NYSE |
Dec 20, 16:00
8.12
+0.02
(+0.25%)
After-Hours: 20:00
Emergent BioSolutions Total Liabilities (Quarterly): 969.40M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Abbott Laboratories | 34.33B |
| Tonix Pharmaceuticals Holding Corp | 20.78M |
| Chimerix Inc | 22.89M |
| Geron Corp | 152.67M |
| MAIA Biotechnology Inc | 7.624M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.478B |
| Shareholders Equity (Quarterly) | 508.40M |
| Debt to Equity Ratio | 1.303 |
| Current Ratio | 2.877 |
| Net Debt Paydown Yield | 10.66% |